top of page

SEMAGLUTIDE
(Ozempic, WeGovy)

Semaglutide is a breakthrough peptide originally developed for type 2 diabetes but now widely recognized for its powerful weight loss benefits. It works by mimicking the GLP-1 hormone, which helps regulate appetite, slow gastric emptying, and improve insulin sensitivity. Users experience reduced hunger, better portion control, and sustained fat loss—often without extreme dieting. Semaglutide also supports heart health, stabilizes blood sugar, and may reduce inflammation. Its once-weekly dosing makes it convenient and effective for long-term use. As part of a holistic health plan, Semaglutide offers life-changing results for those struggling with obesity or metabolic conditions.

Benefits

Weight Loss & Appetite Control
​
  • Significantly reduces hunger and cravings

  • Promotes sustained fat loss

  • Helps with portion control and mindful eating

  • Shown to achieve 15%+ body weight reduction in many users

 
Metabolic & Blood Sugar Regulation
​
  • Improves insulin sensitivity

  • Lowers fasting blood glucose and HbA1c levels

  • Reduces risk of type 2 diabetes progression

  • Supports stable energy levels throughout the day

 
Cardiovascular Benefits
​
  • Lowers blood pressure

  • Reduces LDL cholesterol and triglycerides

  • Decreases risk of heart disease and stroke

 
Hormonal & Digestive Effects
​
  • Slows gastric emptying, leading to prolonged fullness

  • Helps manage metabolic syndrome

  • May improve PCOS-related symptoms in women

 
Additional Benefits
​
  • Once-weekly dosing for convenience and compliance

  • Supports long-term weight maintenance

  • May reduce inflammation and support liver health (e.g., NAFLD)

Side Effects

Common Side Effects (Mild to Moderate):
​
  • Nausea (most common, especially early on)

  • Vomiting

  • Diarrhea or constipation

  • Stomach pain or bloating

  • Fatigue or low energy

  • Loss of appetite (can be a benefit but excessive in some)

  • Headache

  • Indigestion or heartburn

 
Less Common but Notable:
​
  • Dizziness or lightheadedness

  • Injection site irritation (redness, swelling)

  • Dehydration (due to nausea or diarrhea)

  • Mild gallbladder issues (e.g., gallstones)

 
Rare but Serious (Seek Medical Advice):
​
  • Pancreatitis (severe abdominal pain, nausea)

  • Thyroid tumors (seen in rodents; unclear risk in humans)

  • Kidney issues (from dehydration)

  • Severe allergic reaction (rash, swelling, difficulty breathing – extremely rare)

 
Important Notes:
​
  • Starting at a low dose and titrating slowly reduces most side effects

  • Staying hydrated and eating smaller meals helps with nausea

  • Always use under medical supervision

Dosages

1. Starting Dose:
​
  • 0.25 mg subcutaneously once per week

  • Duration: 4 weeks (to allow the body to adjust and minimize side effects)

 
2. Titration Schedule:
​
  • Week 5–8: Increase to 0.5 mg once per week

  • Week 9–12: Increase to 1.0 mg once per week

  • Optional escalation:

    • 1.7 mg per week (after 4+ weeks on 1.0 mg)

    • Maximum: 2.4 mg per week (if well-tolerated and needed)

 
Administration Guidelines:
​
  • Route: Subcutaneous injection (abdomen, thigh, or upper arm)

  • Timing: Same day each week; with or without food

  • Storage: Refrigerate before use

 
Important Notes:
​
  • Always titrate slowly to reduce nausea and GI side effects

  • Combine with lifestyle changes (e.g., physical activity, mindful eating) for best results

  • It's crucial to eat nutritious, whole foods while using Semaglutide, as your overall food intake will be lower—making every bite count for vitamins, minerals, and energy

  • Prioritize proteins, healthy fats, fiber-rich vegetables, and hydration to support muscle retention, energy, and overall health

  • Consult a healthcare provider before making dose changes or combining with other medications

 

Medical Disclaimer: These guidelines are for educational purposes only. Always consult a licensed medical professional before starting any peptide therapy.

  • Telegram
  • Facebook
  • Instagram
  • Twitter
© 2025 thepeptide.guide
bottom of page